Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Clark Daniel Grant — Kiromic Biopharma, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Clark Daniel Grant

Clark Daniel Grant

Chief Financial Officer at Kiromic Biopharma, Inc. · on record since Oct 14, 2021

Insider trading activity of Clark Daniel Grant

Transactions on record: 1; since Aug 15, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Aug 15, 2022

Figures computed from official regulatory filings — methodology.

Companies where Clark Daniel Grant has traded

Kiromic Biopharma, Inc.1 tx · Aug 15, 2022

Track record of Clark Daniel Grant

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Clark Daniel Grant

Co-insiders of Clark Daniel Grant

BERSANI PIETROKiromic Biopharma, Inc.
Catlin MichaelKiromic Biopharma, Inc.
Chiriva Internati MaurizioKiromic Biopharma, Inc.
Cicchetti AmericoKiromic Biopharma, Inc.
Dahlbeck ScottKiromic Biopharma, Inc.
Hungerford BrianKiromic Biopharma, Inc.
Mirandola LeonardoKiromic Biopharma, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Misajon PamelaKiromic Biopharma, Inc.

NAGEL MICHAELKiromic Biopharma, Inc.

Nunez IgnacioKiromic Biopharma, Inc.

Ralston ShannonKiromic Biopharma, Inc.

Reeves KarenKiromic Biopharma, Inc.

Rotino GianlucaKiromic Biopharma, Inc.

Ryan Michael CharlesKiromic Biopharma, Inc.

Schneider Jerry A.Kiromic Biopharma, Inc.

Tirelli Francis XKiromic Biopharma, Inc.

Tontat TonyKiromic Biopharma, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Kiromic Biopharma, Inc.	Aug 15, 2022	Award	50,000	0.00 USD	$0	SEC